NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT04162899,A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04162899,,COMPLETED,"This proposed study is a randomized, double-blind, placebo-controlled, 3-arm parallel, multicenter phase II study, designed to explore the efficacy and safety of SHR0302 treatment for patients with moderate to severe atopic dermatitis.

The study will be conducted over a 12-week treatment period. Two active doses of SHR0302 will be compared to placebo and improvement in atopic dermatitis will be assessed using the Investigator's Global Score (IGA)",YES,Atopic Dermatitis,DRUG: Drug: SHR0302,"The Percentage of Subjects Achieving Investigator's Global Assessment (IGA) Response Which Improvement ≥ 2 From Baseline., The IGA is a validated assessment instrument used in clinical studies to rate the severity of AD globally. IGA response was defined as IGA score of 0/1 (complete or almost complete clearance of skin lesions) with an improvement in IGA score by ≥ 2 from baseline., At week 12","Percentage of Czema Area and Severity Index (EASI) Change., The EASI is a validated measure used in clinical practice and clinical trials to assess the severity and extent of atopic dermatitis (AD)., Up to week 12|Percentage of Subjects Achieving Investigator's Global Score (IGA) Response, The IGA is a validated assessment instrument used in clinical studies to rate The IGA is a validated assessment instrument used in clinical studies to rate the severity of AD globally., Up to week 8|Percent of Pruritus Numerical Rating Scale (NRS) Change, The Pruritus NRS is an assessment tool that participants used to report the intensity of their pruritus during a 24-hour recall period., Up to week 12",,Reistone Biopharma Company Limited,,ALL,"ADULT, OLDER_ADULT",PHASE2,105,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",RSJ10303,2019-11-06,2020-08-21,2020-08-31,2019-11-14,2022-06-28,2023-05-09,"Peking University People's Hospital, Xicheng, Beijing, China|Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, Tianjin, 300120, China|Xuanwu Hospital Capital Medical University, Beijing, 100053, China|Peking University Third Hospital, Beijing, 100083, China|Peking union medical college hospital, Beijing, 100730, China|Beijing Tsinghua Changgeng Hospital, Beijing, 102218, China|The Second Xiangya Hospital of Central South University, Changsha, 410008, China|Xiangya Hospital of Central South University, Changsha, 410008, China|The Third Xiangya Hospital of Central South University, Changsha, 410013, China|Second Affiliated Hospital of Army Medical University (Xinqiao Hospital), Chongqing, 400037, China|The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China|Guangdong Provincial People's Hospital, Guangzhou, 510000, China|Sun. Yat- Sen Memorial Hospital, Sun. Yat- Sen University, Guangzhou, 51000, China|The first affiliated hospital Zhejiang university, Hangzhou, 310003, China|Affiliated Hangzhou first people's hospital, Zhejiang university school of medicine, Hangzhou, 310006, China|Zhejiang province People's Hospital, Hangzhou, 310014, China|Jinan Central Hospital, Jinan, 250013, China|Shanghai Skin Disease Hospital, Shanghai, 200050, China|The first hospital of China medical university, Shenyang, 110001, China|The First Affiliated Hospital of Soochow University, Suzhou, 215006, China|The First Hospital of Shanxi Medical University, Taiyuan, 030001, China|Union Hospital Affiliated with Tongji Medical College of Huazhong University of Science and Technology, Wuhan, 430022, China|Henan provincial people's hospital, Zhengzhou, 450003, China","Study Protocol, https://storage.googleapis.com/ctgov2-large-docs/99/NCT04162899/Prot_000.pdf|Statistical Analysis Plan, https://storage.googleapis.com/ctgov2-large-docs/99/NCT04162899/SAP_001.pdf"
